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Introduction: Bronchopulmonary sequestration (BPS) may cause prenatal pleural effu-
sion (PE) or even hydrops. This case describes a fetus presenting with severe PE, which 
prenatally waned completely under steroid treatment, yet surprisingly reappeared rapidly 
after birth, requiring early surgical intervention.
Case description: A male fetus was diagnosed with left BPS and severe PE. After three 
courses of prenatal steroid therapy for each recurrence of PE from 27 weeks of gestation, 
we observed a complete regression of PE prenatally. Yet, PE recurred 18 h after birth 
and persisted after repeated drainages and steroid therapy. Early total resection of the 
extralobar BPS was performed and led to complete recovery without recurrence of PE.
Conclusion: This report underlines that in cases of BPS presenting with prenatal PE 
needing fetal intervention, even if full regression of PE is observed before birth, there 
might be a need for surgical excision during the neonatal period.
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INtRoDUCtIoN
Routine ultrasound screening during pregnancy usually may allow for the early detection of 
bronchopulmonary malformations. Various congenital lung lesions may present with associated 
complications, such as pleural effusion (PE), mediastinal shift, hydrops, and polyhydramnios. In the 
case of bronchopulmonary sequestration (BPS), up to one-third of fetuses present with severe PE 
or hydrops and require prenatal intervention (1, 2). Among these complications, hydrops has been 
shown to be the single prenatal outcome predictor for mortality (2, 3). Perinatal mortality concerns 
about 10% of babies presenting with BPS (2). Of note, 17% of infants born with BPS will present 
symptoms requiring emergency surgery during the first month of life (4). However, most of the 
infants will develop symptoms only later on, with an average time of onset of symptoms in prenatally 
detected lung lesions of about 7 months, thus only needing elective surgery during early infancy (4).
Case RepoRt
A 26-week-old male fetus presented with a pulmonary mass of 19 cm3, seen at standard ultrasound 
screening in our tertiary university hospital. A feeding vessel originating from the aorta was visualized 
Abbreviations: BPS, bronchopulmonary sequestration; PE, pleural effusion.
FIgURe 1 | Prenatal course of pleural effusion (PE) and its treatment. In total, 
three courses of betamethasone were administrated, allowing for complete 
prenatal regression of the PE.
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and suggested the diagnosis of BPS. Weekly ultrasound monitoring 
was performed thereafter. At 27 weeks of gestation, moderate PE 
appeared, for which intramuscular betamethasone was adminis-
tered to the mother. Ultrasound follow-up showed fluctuation 
of PE with good response to steroids at each recurrence. Three 
courses of betamethasone 2  mg/day for 2  days were adminis-
trated in total at 27 5/7, 31 2/7, and 34 1/7 weeks of gestation, with 
PE regression after each course. Amniodrainage was performed 
at 32  weeks for polyhydramnios (amniotic fluid index 44), 
because of maternal discomfort and risk of premature rupture 
of membranes, which yet recurred thereafter. At 34 weeks, when 
the thoracic lesion measured 23 cm3, scalp edema was observed 
concomitant with PE, however, followed by its complete regres-
sion after the third administration of betamethasone. Prenatal 
course of PE is summarized in Figure 1.
At 35 5/7 weeks, premature rupture of membranes occurred, 
probably due to recurrence of polyhydramnios and previous 
drainage. Cardiotocogram during labor was without pathological 
findings and vaginal delivery was uncomplicated. The newborn 
adapted well with Apgar score of 8/10/10. Birth weight was 
2,570 g (P10–P50). There was no sign of respiratory distress or 
cardiovascular compromise. A first X-ray performed 4  h after 
birth showed a left basal thoracic mass without significant PE 
(Figure 2A). Yet, the newborn developed respiratory distress at 
the age of 18 h requiring treatment with high flow nasal cannula. 
X-ray showed massive left sided PE causing mediastinal shift 
(Figure  2B). Immediate pleural drainage allowed for clinical 
improvement. The analysis of the pleural fluid showed low protein 
and low leukocyte content compatible with transudate.
Persistent active pleural drainage during the following 
days lead to radiological work-up by ultrasound and CT-scan 
confirming the diagnosis of extralobar BPS, measuring 
3.9 cm × 4.8 cm × 3.9 cm, with a feeding vessel originating from 
the aorta at the level of the diaphragm.
At 1 week of age, pleural drainage increased up to 80 ml/kg/
day. Dexamethasone was administered for 1 week, at a decreasing 
dosage of 0.15 mg/kg/day for 3 days to 0.1 mg/kg/day, followed by 
complete resolution of PE, and thus removal of the chest tube. One 
day after discontinuation of the steroid treatment, PE recurred 
needing a new chest tube insertion. Early excisional surgery was 
then considered as inevitable, and at day 27 the extralobar BPS 
was removed by thoracotomy. Histological analysis confirmed 
diagnosis of BPS and extensive pleuropulmonary lymphatic 
dilatation. Post-operative course was uneventful with complete 
recovery within days.
DIsCUssIoN
The antenatal discovery of a cystic or solid lung malformation 
opens a range of diagnosis, with the most frequent being con-
genital pulmonary airway malformation and BPS. Recent studies 
show that even the distinction between these two entities is not 
so clear with the discovery of an increasing number of “hybrid” 
lesions (3). Natural fetal evolution of these lesions may either 
tend toward enlargement, or to steady state, or even to partial/
complete regression (3). When presenting antenatal complica-
tions, such as massive PE, with or without mediastinal shift, or 
even hydrops, fetal intervention may be required (5). Pleural–
amniotic shunting is an option in these cases. BPS offers more 
specific therapeutic options by acting on the feeding vessel by 
laser, radiofrequency, or embolization. A recent study comparing 
pleuroamniotic drainage to laser ablation of the feeding vessel 
showed a tendency toward an advantage for ablation of the feed-
ing vessel, even though numbers are too small to demonstrate 
a definitive advantage (1). In the case of microcystic lesions, 
maternal steroid treatment with betamethasone has shown to 
be a safe and efficient by reducing hydrops and also the size of 
the lesions. Of note, no adverse maternal or fetal events result-
ing from betamethasone administration have been reported (6). 
It is believed that the administration of steroids allows for lung 
maturation in these bronchopulmonary malformations, which 
are considered as an arrested state of development. Yet, the role 
of maternal betamethasone treatment in BPS has not been clearly 
established due to their relative lower incidence (7). In our case, 
where steroid administration was chosen, the fetus responded to 
repeated courses of betamethasone with complete regression of 
PE and decrease in size of the BPS.
Because there is a twofold increase in risk of operative compli-
cations in symptomatic patients, elective surgery is aimed to be 
performed before appearance of symptoms, such as respiratory 
distress or infection (4). Average time of onset of symptoms is 
reported to be at the age of about 10 months, taking into consid-
eration both infants diagnosed prenatally and those who were 
not (4). Thus, most pediatric surgeons generally plan elective 
surgery in infants presenting with congenital lung lesions at the 
age of 6–12  months (8). The reported neonate was completely 
asymptomatic at birth, and also once the postnatally recurrent PE 
was drained, allowing time for observation of natural evolution 
of the PE. In addition, we attempted a conservative treatment 
with corticosteroids, since this was effective during pregnancy. 
Response was favorable, but did not avoid recurrence of PE. 
We then chose to perform surgery to avoid prolonged pleural 
drainage, with the risk of infection, as well as long-term steroid 
treatment, associated with its well-known side effects.
To the best of our knowledge, the postnatal recurrence of PE 
after complete antenatal regression has not been described in 
FIgURe 2 | (a) X-ray 4 h after birth showing left basal thoracic mass, without significant pleural effusion (PE); (B) X-ray at 18 h of age showing a massive left sided 
PE causing mediastinal shift.
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the literature. The reason for postnatal recurrence of PE remains 
unclear. Reports suggest that severe PE might be due to obstruc-
tion of venous return due to compression by the BPS, cardiac 
failure due to shunting through the lesion or obstruction of 
lymphatic return. The chemical and cytological analysis of the 
pleural liquid, compatible with transudate, is in line with this 
hypothesis. Histological examination in our case showed marked 
lymphatic dilatation, a potential explanation for recurrent PE in 
our case: steroids may have influenced the local lymphatic tissue, 
yet without persistent effect.
CoNCLUDINg ReMaRKs
Antenatal ultrasound scan is a sensitive tool, which offers early 
detection of BPS and its antenatal complications, and thus guides 
intervention. These measures may lead to complete antenatal 
resolution of PE. Nevertheless, this case illustrates that, despite 
a favorable antenatal course, there is a probability that surgical 
intervention during the neonatal period still might be required 
due to recurrence of PE after birth.
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